Insulet's Revenue Surges; Stock Soars 21%
Insulet (NASDAQ: PODD) reported strong second-quarter 2019 results after the market close on Monday, Aug. 5. The tubeless insulin pump specialist delivered revenue growth of 43% year over year and its earnings flipped to positive, from negative in the year-ago period.
The company turned profitable in the third quarter of last year and has posted a profit in each of the three quarters since then.
Shares soared to a closing gain of 21.4% on Tuesday. We can attribute the market's reaction to revenue coming in higher than many investors were likely expecting and to the company, once again, increasing its full-year 2019 revenue guidance -- and by a hefty amount. In 2019, shares have gained 80.5% through Tuesday, versus the S&P 500's 16.3% return.
Quelle Fool.com
